🔗 Share this article

Treasury head Reeves has announced she is preparing "targeted action to tackle household expense challenges" in next month's financial statement.

Speaking to media outlets, she stated that reducing inflation is a shared responsibility of both the administration and the central bank.

The UK's price growth is forecast to be the highest among the Group of Seven advanced economies this year and the following year.

Potential Utility Cost Measures

It is understood the government could take action to reduce energy bills, for example by cutting the current 5% level of VAT charged on energy.

An additional possibility is to cut some of the government charges currently added to bills.

Budgetary Constraints and Expert Expectations

The government will obtain the next assessment from the official forecaster, the OBR, on Monday, which will reveal how much space there is for such actions.

The view from the majority of experts is that Reeves will have to announce tax rises or expenditure reductions in order to meet her voluntary fiscal targets.

Earlier on the same day, analysis suggested there was a £22bn shortfall for the Treasury chief to fill, which is at the lower end of projections.

"It is a collective responsibility between the Bank of England and the administration to bear down further on some of the drivers of price increases," the Chancellor informed the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Revenue Commitments and International Concerns

While much of the attention has been on likely tax rises, the Treasury chief said the most recent figures from the fiscal watchdog had not changed her pledge to election pledges not to raise rates on income tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with increasing geopolitical and commercial tensions for the Budget revenue measures, probably to be directed on those "with the broadest shoulders."

International Economic Tensions

Commenting on concerns about the UK's commercial links with China she said: "Our national security invariably take priority."

Last week's declaration by China to strengthen trade restrictions on rare earths and other resources that are essential for high-technology manufacturing led US President Donald Trump to propose an further 100% tariff on goods from the Asian country, increasing the risk of an full-scale trade war between the two largest economies.

The US Treasury Secretary described the Chinese action "economic coercion" and "a international production control attempt."

Questioned on considering the US offer to participate in its conflict with the Asian nation, Reeves said she was "extremely troubled" by China's measures and encouraged the Chinese government "not to put up barriers and limit trade."

She said the decision was "bad for the global economy and generates further headwinds."

"In my view there are areas where we need to confront Chinese policies, but there are also valuable chances to trade with Chinese markets, including banking sector and other sectors of the economic system. We've got to maintain that equilibrium right."

The chancellor also stated she was collaborating with G7 counterparts "regarding our own essential resources approach, so that we are reduced dependence."

NHS Medicine Costs and Investment

The Chancellor also recognized that the cost the National Health Service spends on medicines could go up as a consequence of current negotiations with the US government and its drugs companies, in exchange for lower tariffs and capital.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping operations in the United Kingdom, with several attributing the modest returns they are obtaining.

Last month, the Science Minister said the cost the NHS spends on drugs would need to go up to stop companies and pharmaceutical investment departing from the UK.

Reeves told media: "We have seen because of the cost structure, that drug testing, innovative medicines have not been available in the United Kingdom in the way that they are in other continental states."

"The objective is to make sure that people getting care from the National Health Service are able to receive the top essential drugs in the globe. And so we are looking at this situation, and... looking to attract more investment into the UK."